Concepedia

Publication | Open Access

Randomized Dose-Escalation Study Evaluating Peginterferon Alfa-2a in Patients With Metastatic Malignant Melanoma

DOIFull Paper Access

74

Citations

23

References

2006

Year

Reinhard Dummer, Claus Garbe, John A. Thompson, Alexander Eggermont, Kisook Yoo, Tanja Maier, B. Bergström
Journal of Clinical Oncology

Abstract

PEG-IFNalpha-2a at doses up to 450 mug once weekly has shown good tolerability and similar efficacy to conventional IFNalpha and monochemotherapy in stage IV metastatic melanoma.

References

YearCitations

Page 1